Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • A Pujan Ceremony Marks SPARSH Hospitals’ Entry into Final Phase of Unveiling New Hennur Facility in Mid-May Health
  • Koffelo Launches NOC, India’s Fastest Cold Brew Shot That Delivers Café-Style Coffee in 5 Seconds Business
  • SEPC Limited Order Book Scales New Peak; Rs 10,455 Crore Business
  • Lilavati Hospital and Mayo Clinic Conclude India’s First ‘Nursing Excellence Training Program’ in Mumbai Business
  • First-ever Chess for Kids book in Hindi with story-telling narrative Press Release
  • Is 2022 the same as 1962 (Indo China War) Press Release
  • Vikas Lifecare to launch a Rs 200 crore QIP, company to raise Rs 50 cr in 1st tranche Business
  • What’s Next for Digital? In Conversation With Wire Monster CEO Siddharth Bhan Business

Chandan Healthcare Sharpens Focus on High-Margin Diagnostics Business Through Strategic Divestment

Posted on August 8, 2026 By

Lucknow (Uttar Pradesh) [India], August 8: Chandan Healthcare Limited (NSE – CHANDAN), one of the leading diagnostic and healthcare services providers, has announced the strategic divestment of its entire shareholding in Chandan Pharmacy Limited (“CPL”), reinforcing its focus on scaling its core, higher-margin diagnostics business.

The divestment aligns with Chandan Healthcare’s strategy to sharpen its focus on the higher-margin diagnostics business. The transaction will simplify the business structure and enable greater management and capital allocation towards expanding the Company’s core diagnostics operations.

Key Strategic Benefits

  • Improved Margin Profile: Deconsolidation of the lower-margin pharmacy business is expected to improve the overall business mix and enable the stronger profitability of diagnostics to reflect more clearly in the Company’s consolidated financial performance.
  • Sharper Focus on Core Diagnostics: Greater management bandwidth and resources can be directed towards expanding the diagnostics network, increasing capacity utilisation and scaling the Company’s core operations.
  • Capital Redeployment Towards Higher-Return Assets: Proceeds from the divestment are proposed to be deployed towards the development of new diagnostic centres and capacity expansion. This will enable the Company to reallocate capital from a lower-margin business towards higher-EBITDA opportunities.
  • Simplified Business Structure: A more focused diagnostics-led structure is expected to provide greater visibility into the scale, growth and profitability of the core business while enabling more relevant benchmarking with diagnostics-focused peers.

Transaction Details

The Board has approved the divestment of Chandan Healthcare’s entire 53.56% stake in Chandan Pharmacy Limited to Chandan Hospital Limited for a consideration of approximately ₹16.77 crore. The consideration is based on CPL’s independently determined total valuation of approximately ₹31.31 crore, following which CPL will cease to be a subsidiary of the Company.

Building a Focused Diagnostics Platform

Going forward, Chandan Healthcare intends to deploy greater financial and managerial resources towards expanding its diagnostics footprint, adding new centres, strengthening capacity and driving higher utilisation across its network.

The strategic realignment is expected to result in a simpler and more focused business structure, with a stronger margin profile and future growth increasingly driven by the scale-up of the Company’s core diagnostics operations.

About Chandan Healthcare Limited

Chandan Healthcare Limited, established in 2003, is one of India’s leading providers of diagnostic and pharmacy services and a key entity of the Chandan Group. The Company delivers a comprehensive range of pathology and radiology services through its expanding network across India.

As on June 30, 2026, the Company operates 327 diagnostic centres including 264 operational franchise centres, strengthening its presence across urban, semi-urban and emerging markets. Its diagnostic portfolio comprises more than 3,000 pathology tests and 500+ radiology tests, including blood tests, X-ray, ECG, Ultrasound, CT scan, MRI and several other specialized diagnostic investigations. The Company’s network includes NABL and NABH accredited pathology laboratories and radiology centres, reflecting its commitment to delivering reliable, high-quality diagnostic services.

Chandan Healthcare operates through a diversified business model comprising B2C (Retail Customers), B2B (Institutional & Corporate Clients) and B2G (Government PPP Contracts), providing a balanced and scalable revenue profile while catering to a wide spectrum of healthcare needs.

The Company was listed on the NSE Emerge platform on February 17, 2025. 

During FY26, the Company reported Total Income of ₹280.67 Cr, EBITDA of ₹56.84 Cr and Profit After Tax (PAT) of ₹27.06 Cr, reflecting its continued operational growth and financial strength.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Business Tags:Business

Post navigation

Previous Post: Intense Technologies Reports Q1 FY27 Results; Strengthens Growth with New Client Wins, AI-led Innovation and Global Expansion
Next Post: Paul Merchants Gets RBI Approval for Perpetual AD Category-II Licence Under Revised FEMA Framework

Related Posts

  • Eye Opener for Giant Pharma Bulls!!! Business
  • Sanjay Malhotra, Secretary, Financial Services, presided over Financial Inclusion Campaign on Vittiya Samaveshan Se Sashaktikaran Business
  • Influencer Hetaa Ramani endorses Decoraids’ innovative ceiling tiles and wall panels Business
  • Landmark 2 billion COVID-19 certificates issued across 5 countries Business
  • BillionE Mobility Receives India’s Largest EV Truck Delivery from Tata Motors and Expands Fleet to Accelerate EV Freight Transition Business
  • Elevating has a new meaning: Adsparkx celebrates its 10th Annual Day Business

Recent Posts

  • Red Chief launches ‘No Shortcuts Cypher’ to spotlight emerging Desi Hip-Hop talent
  • Haworth Unveils the Future of Workspaces, Build for Those Who Build India, at ORGATEC India 2026
  • Crystal-Clear Lagoons and Coral Reefs: Why Lakshadweep Is Worth Visiting
  • Gambol Pioneers Experiential Sports Retail with a 15,000 Sq. Ft. Multi-Brand Flagship in Ahmedabad
  • What redRail by redBus Adds to the Online Train Booking Experience

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Sugarskull-dessert specialist and not a food blogger English
  • Influencerquipo Presents Creative Lifestyle Blogger of the Year – Devki (The Snazzy Diva) Lifestyle
  • SGT University Hosts Scholarship Distribution Ceremony to Support and Empower Meritorious Students Education
  • BE Hub Invites Visionary AI & ML Entrepreneurs to Join Its Startup Ecosystem Business
  • World Book of Records (UK) Awards & Summit in Tunisia Celebrates Global Excellence with 50 Countries and Silver Jubilee of International Siddhashram Shakti Centre, UK Lifestyle
  • Hallmark Infra-con (India) Private Limited has unveiled a new chapter of Ultra-Luxury Living at the Most Premium Locations of Hyderabad Business
  • Ahmedabad based JVS Technologies Pvt Ltd launches SoftClinic GenX: India’s first ZERO Cost AI-Powered Digital Prescription App Business
  • IMMA Summit discusses ‘Ease of Doing Business’ and Unveils AI-Driven Drones and Digitization as the Future of Farming in India Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme